Metacon
Metacon secures temporary project financing of SEK 20 million
"With project financing in place to manage the most recent contracts, the Company's short-term financing needs have been addressed" says Christer Wikner, President & CEO, Metacon.
The Loan carries an interest rate of 2.0 percent per commenced 30-day period and has a setup fee of 5.0 percent. Repayment of the Loan is to be made no later than on 31 August 2025. The purpose of the financing is to secure the Company's working capital needs until the Company receives milestone payments related to ongoing customer projects.
Contact:
Christer Wikner, President & CEO, +46 707 647 389, christer.wikner@metacon.com
Mattias Jansson, CFO, +46 722 316 862 mattias.jansson@metacon.com
This information is information that Metacon AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact persons set out above, at 07:30 CEST on 26 May 2025.
About Metacon AB (publ)
Metacon AB (publ) develops and manufactures energy systems to produce fossil-free "green" hydrogen. In the Electrolysis business unit and in close partnership with world leader PERIC Hydrogen Technologies, Handan, China, Metacon offers complete electrolysis plants for large-scale production of hydrogen. Metacon also offers production-integrated hydrogen refueling stations, a globally growing area within clean transport. The products in the Reforming business unit are based, among other things, on Metacon's patented HIWAR® technology that generates hydrogen through catalytic steam reforming of biogas or other hydrocarbons such as bioethanol. The development of Metacon's reforming products is carried out within the wholly owned subsidiary Metacon S.A. in Patras, Greece. The business is focused on catalytic process chemistry and advanced, compact reformers for high-efficiency hydrogen production. www.metacon.com
For further information, see:
www.metacon.com | X: @Metaconab| LinkedIn: www.linkedin.com/company/metaconab
Datum | 2025-05-26, kl 07:30 |
Källa | Cision |
